ACTION ALERT:
Contact:
Alexander Runko, Ph.D.
Division of Investigative Oversight
Office of Research Integrity
Via email: [email protected]
[email protected]
Dr. Runko,
Fraudulent research must not be tolerated. You must convict William
Armstead, formerly of the University of Pennsylvania, of Research Misconduct
for the five fraudulent publications, which were retracted because "it was
discovered that the data in the article could not be substantiated by the
source data.”
This is not anything that even roughly resembles science; it is nothing but
fraud. Armstead must be convicted of Research Misconduct, and he must
receive the maximum penalty.
Brain-injury scientist leaves Penn amid investigation of five studies on pigs
From Tom Avril, Inquirer.com, September 6, 2022
William Armstead tested drugs to treat brain injuries in piglets and
juvenile pigs, but left Penn after notifying officials of "inconsistencies."
A longtime University of Pennsylvania scientist has left the school amid an
investigation into “inconsistencies” in five experiments that involved
injuring the brains of piglets and juvenile pigs, the results of which have
now been retracted by the scientific journals that published them.
William M. Armstead has shut down the lab where he did the research, testing
various drugs to treat the pigs so as to identify possible therapies for
humans with traumatic brain injury. As described in the published findings,
several of the drugs appeared to hold promise. But in each case, Armstead
told the journals that the published data did not match the results that his
team recorded when doing the experiments, editors wrote in notices of the
retractions.
Neither the journals nor Penn officials provided details about the
discrepancies in the results, such as whether they were the result of
mistakes or deliberate misconduct. But given that issues arose on five
separate occasions, the latter scenario is plausible, said physician Ivan
Oransky, co-founder of Retraction Watch, the science news site that first
reported on Armstead’s departure.
“It looks an awful lot like a pattern,” said Oransky, who teaches medical
journalism at New York University.
Armstead did not respond to requests for comment from The Inquirer sent to
what appeared to be his LinkedIn account and via a letter left at his home
in Center City. Efforts to reach several of his co-authors also were
unsuccessful.
Asked about the research, Penn officials said in a statement:
“When a journal made us aware of inconsistencies in data submitted by Dr.
Armstead, we evaluated the concerns in accordance with our process and
reported our findings to all appropriate agencies. Dr. Armstead is no longer
a faculty member at Penn, has closed his lab and ended his animal research
activities.”
A university spokesperson said he left during the past academic year. On the
LinkedIn page that matches his credentials, a Penn scientist named William
Armstead is listed as starting a new job in March at a medical education
company. But a receptionist at that company said no one named Armstead is
now working there.
How the Penn team studied brain injury
In one study, Armstead and his co-authors described the technique they used
to injure each of the pigs’ brains in precisely the same way. They drilled a
hole in each pig’s skull, positioned a cylinder of fluid against the exposed
outer layer of the brain, then delivered a “pressure pulse” to the brain by
striking the other end of the cylinder with a weighted pendulum.
There is no indication that Penn’s investigation or the federal review
involves questions about the research technique itself. Such experiments
have been performed on pigs for years by Armstead’s team and others. But if
the results of such experiments are invalid due to misconduct, that’s an
affront not only to the animals, but to taxpayers and other scientists, said
Retraction Watch’s Oransky.
“If you hurt an animal for no reason, because you’re actually committing
fraud, that’s pretty heinous,” he said.
As originally published, the study results suggested several drugs were
effective in treating the injuries. But all five studies were retracted
between April and August.
Three were published in the Journal of Neurotrauma, one in Pediatric
Critical Care Medicine, and another in Pediatric Research.
Mary Ann Liebert Inc., which publishes the Journal of Neurotrauma, said
Armstead had emailed to request the retraction of the studies due to
“substantive questions” about the findings. He declined to provide more
details, according to an editor’s note.
“On three separate occasions, both the publisher and editor requested
additional information detailing the specifics of the questions which were
raised that invalidated the findings in the study, but did not receive a
response from Dr. Armstead,” the note stated. “Despite being unable to
ascertain more unambiguous information, the Editor-in-Chief of the Journal
of Neurotrauma agreed to Dr. Armstead’s request for a retraction after
receiving agreements from the article’s coauthors.”
University investigations into allegations of research misconduct generally
must be reported for review by the Office of Research Integrity, a unit of
the U.S. Department of Health and Human Services that is tasked with
overseeing the proper use of federal research funds.
The office does not publicly confirm it is reviewing the results of
university investigations until they are resolved. But in this instance, the
agency said it is “conducting an oversight review and will take appropriate
actions” in an email to Stop Animal Exploitation NOW!, an Ohio-based
nonprofit that opposes experiments on animals. The organization posted the
email on its website.
In a resume posted on the website of a neuroscience research society,
Armstead is listed as starting at Penn in 1992. In the 1990s, he also was
affiliated with Children’s Hospital of Philadelphia, the resume says. As of
June, Penn’s web site said Armstead “may no longer be affiliated” with the
university’s Perelman School of Medicine, and now it says he has “retired.”